Clinical Trial Update: B-type Natriuretic Peptide (BNP) in Human Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating B-type natriuretic peptide for hypertension was terminated, representing a status update rather than a definitive result.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Mayo Clinic | Conditions: Hypertension Stage 1 | Phase 1 | Status: TERMINATED